Yes, ebola seems to be all over the news, but let’s put things
back into perspective: heart disease and lung cancer still contribute to more US deaths than ebola, at least so far.

One article that we received last week seeks to dispel five cancer care myths:

First Myth: “Supportive Care is Overused.”
According to the article, it is actually misused rather than overused.

Second Myth: “Cancer Care Treatment at the End of Life is of Low Value.” The article actually shows not that it is of low value, but rather
than patients are often typically not willing to spend their own money at this stage.

Third Myth: “Treatment Costs Are Unsustainable. While costs are rising and cannot continue at the current pace, it’s not always true that an individual cancer patient’s treatment costs are unsustainable. Out-of-pocket expenses can be managed with the right health coverage: ‘members who purchase insurance with good benefits will pay a higher premium, but their coverage will make their individual cost more sustainable.’”

Fourth Myth: “Detection, Not Treatment, Accounts for Most of the Survival Gain. The number of adult cancers with significant improvement in survival due to treatment breakthroughs is impressive, but the U.S. medical system is missing a great opportunity to quickly learn about new therapies by failing to enroll adults in clinical trials, writes Newcomer. Only about 3 percent of adult cancer patients are enrolled in clinical trials. In contrast, nearly every child cancer patient is enrolled in a trial; as a result pediatric cancer survival has seen impressive results. Although the number of trials being offered is diminishing in concert with decreased funding and lengthy approval processes, the U.S. cancer research system is giving priority to collaboration, speed and access, resulting in new approaches to treatment.”

Fifth Myth: “The War on Cancer Has Been a Failure…Research shows that advances in the ways that cancer is diagnosed and treated have increased the number of people who live disease-free for long periods of time, according to the National Cancer Institute. ‘Researchers, patient advocates, and policy makers should, nevertheless, push harder to improve the rate of progress. Finding ways to make cancer care affordable must be an important part of that effort.’”

So, have we successfully re-prioritized your concerns?

If you have concerns about your health insurance coverage, please give us a call at 877.789.5831, or complete the confidential form below and one of our experts will be in touch with you right away!